SyntheticMR Future Growth
Future criteria checks 4/6
SyntheticMR is forecast to grow earnings and revenue by 89% and 18% per annum respectively. EPS is expected to grow by 89% per annum. Return on equity is forecast to be 16.2% in 3 years.
Key information
89.0%
Earnings growth rate
89.0%
EPS growth rate
| Healthcare Services earnings growth | 25.8% |
| Revenue growth rate | 18.0% |
| Future return on equity | 16.2% |
| Analyst coverage | Low |
| Last updated | 02 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 125 | 30 | 16 | 10 | 2 |
| 12/31/2025 | 98 | 14 | 1 | 0 | 2 |
| 12/31/2024 | 76 | 1 | -10 | -9 | 2 |
| 6/30/2024 | 87 | 5 | -7 | 2 | N/A |
| 3/31/2024 | 96 | 16 | -17 | -8 | N/A |
| 12/31/2023 | 94 | 10 | -17 | -7 | N/A |
| 9/30/2023 | 85 | 6 | -19 | -9 | N/A |
| 6/30/2023 | 83 | 6 | -26 | -15 | N/A |
| 3/31/2023 | 80 | 7 | -28 | -17 | N/A |
| 12/31/2022 | 74 | 6 | -26 | -15 | N/A |
| 9/30/2022 | 71 | 8 | -19 | -9 | N/A |
| 6/30/2022 | 65 | 7 | -12 | -4 | N/A |
| 3/31/2022 | 58 | 2 | -6 | 0 | N/A |
| 12/31/2021 | 63 | 8 | -1 | 4 | N/A |
| 9/30/2021 | 60 | 8 | -1 | 3 | N/A |
| 6/30/2021 | 57 | 5 | -8 | -3 | N/A |
| 3/31/2021 | 55 | 3 | -9 | -3 | N/A |
| 12/31/2020 | 52 | 1 | -14 | -9 | N/A |
| 9/30/2020 | 47 | -6 | -14 | -9 | N/A |
| 6/30/2020 | 48 | -3 | -5 | -1 | N/A |
| 3/31/2020 | 51 | 2 | -2 | 3 | N/A |
| 12/31/2019 | 48 | 4 | 9 | 13 | N/A |
| 9/30/2019 | 53 | 12 | 11 | 14 | N/A |
| 6/30/2019 | 52 | 13 | 15 | 18 | N/A |
| 3/31/2019 | 50 | 14 | 18 | 21 | N/A |
| 12/31/2018 | 51 | 15 | 15 | 18 | N/A |
| 9/30/2018 | 49 | 14 | 16 | 19 | N/A |
| 6/30/2018 | 45 | 12 | 12 | 15 | N/A |
| 3/31/2018 | 39 | 8 | N/A | 14 | N/A |
| 12/31/2017 | 38 | 8 | N/A | 11 | N/A |
| 9/30/2017 | 34 | 8 | N/A | 11 | N/A |
| 6/30/2017 | 30 | 7 | N/A | 9 | N/A |
| 3/31/2017 | 28 | 6 | N/A | 6 | N/A |
| 12/31/2016 | 22 | 2 | N/A | 4 | N/A |
| 9/30/2016 | 15 | 1 | N/A | 0 | N/A |
| 6/30/2016 | 14 | 4 | N/A | -1 | N/A |
| 3/31/2016 | 11 | 1 | N/A | -3 | N/A |
| 12/31/2015 | 9 | 0 | N/A | -5 | N/A |
| 9/30/2015 | 7 | -4 | N/A | -5 | N/A |
| 6/30/2015 | 5 | -9 | N/A | -6 | N/A |
| 3/31/2015 | 5 | -8 | N/A | -4 | N/A |
| 12/31/2014 | 4 | -7 | N/A | -3 | N/A |
| 9/30/2014 | 5 | -6 | N/A | -3 | N/A |
| 6/30/2014 | 5 | -5 | N/A | -3 | N/A |
| 3/31/2014 | 5 | -5 | N/A | -3 | N/A |
| 12/31/2013 | 4 | -5 | N/A | -4 | N/A |
| 9/30/2013 | 4 | -4 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9480's forecast earnings growth (89% per year) is above the savings rate (0.8%).
Earnings vs Market: 9480's earnings (89% per year) are forecast to grow faster than the German market (20% per year).
High Growth Earnings: 9480's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 9480's revenue (18% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: 9480's revenue (18% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9480's Return on Equity is forecast to be low in 3 years time (16.2%).